Acid Reflux Solutions

Acid Reflux Treatments

FDA Accepts New Drug Application (NDA) For Rabeprazole Sodium Extended-Release 50 Mg For Patients With Gastroesophageal Reflux Disease (GERD)

June 4th, 2010 | Author: admin

Eisai Inc. (Headquarters: Woodcliff Lake, NJ; Chairman and CEO: Hajime Shimizu), a U.S.

Read the original post:
FDA Accepts New Drug Application (NDA) For Rabeprazole Sodium Extended-Release 50 Mg For Patients With Gastroesophageal Reflux Disease (GERD)

Posted in Acid Reflux News | Tags: acid reflux, acid reflux / gerd, acid-reflux-gerd-news, aciphex, cancer-oncology, health-articles, health-news, healthcare-news, lung-cancer, medicine-articles, plastic-surgery, view-more-news-, welfare

Leave a Reply